KVUE
CFO musical chairs
Kenvue just said Heather Howlett will step in as interim chief financial officer and chief accounting officer starting May 12, 2026. That’s the same day Amit Banati is set to step down, so this isn’t a mystery departure so much as a planned handoff with a fresh nameplate.
Why this matters
The CFO chair is not just a fancy office with a good view. It’s where the company’s story gets translated into numbers, guidance, and investor trust. So when a consumer-health giant is already dealing with a pending Kimberly-Clark acquisition and no 2026 outlook, a finance leadership change can feel like swapping pilots mid-flight.
The bigger backdrop
The article also notes Kenvue has been getting a lot of Street attention lately:
- UBS bumped its price target to $19 from $17
- Canaccord Genuity lifted its target to $18 while keeping a Hold rating
- Barclays raised its target to $19
- BofA resumed coverage without a rating, pointing to the pending deal with Kimberly-Clark
That’s a lot of analysts basically saying, “Interesting company, complicated setup.” Which, frankly, is Wall Street’s favorite sentence.
Big picture
This is not a blockbuster catalyst by itself, but it adds another layer of transition risk around a stock already living in merger limbo. If you own KVUE, the question isn’t just who runs finance next — it’s how much of Kenvue’s standalone future is even left to price in.